Preferential block of late sodium current in the LQT3 ΔKPQ mutant by the class I(C) antiarrhythmic flecainide

Molecular Pharmacology

Volumn 57, Issue 1, 2000, Pages 101-107

  Nagatomo, Toshihisa ^a,b   January, Craig T ^a   Makielski, Jonathan C ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE; SODIUM CHANNEL;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HEART DEPOLARIZATION; HUMAN; HUMAN CELL; LONG QT SYNDROME; PATCH CLAMP; PRIORITY JOURNAL; SODIUM CURRENT;

ANTI-ARRHYTHMIA AGENTS; BINDING SITES; CELLS, CULTURED; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FLECAINIDE; HUMANS; LONG QT SYNDROME; MODELS, MOLECULAR; MUTATION; QUALITY CONTROL; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS;

EID: 0033982867     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. + channels. Circ Res 79:103-108.
2. Anno T and Hondeghem LM (1990) Interactions of flecainide with guinea pig cardiac sodium channels: Importance of activation unblocking to the voltage dependence of recovery. Circ Res 66:789-803.
3. Bennett PB, Yazawa K, Makita N and George Jr AL (1995) Molecular mechanism for an inherited cardiac arrhythmia. Nature (Lond) 376:683-685.
4. CAST investigators (1989) Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321:406-412.
5. + channel-linked long-QT syndrome. Circ Res 78:916-924.
6. + channels expressed in a mammalian cell line. J Physiol 496:275-286.
7. Follmer CH, Cullinan CA and Colatsky TJ (1992) Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: Evidence for open channel block and unblock. Cardiovasc Res 26:1130
8. + channel α-subunit gene (SCN5A) to band 3p21. Cytogenet Cell Genet 68:67-70.
9. + channel inactivation gating. Circ Res 76:114-122.
10. Hille B (1977) Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497-515.
11. Hondeghem LM and Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472: 373-398.
12. Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, Timothy K, Taggart RT, Schwartz PJ, Vincent GM, Moss AJ, Keating MT (1994) Two long QT syndrome loci map to chromosome 3 and 7 with evidence for further heterogeneity. Nat Genet 8:141-147.
13. Johns JA, Anno T, Bennett PB, Snyders DJ and Hondeghem LM (1989) Temperature and voltage dependence of sodium channel blocking and unblocking by O-demethyl encainide in isolated guinea pig myocytes. J Cardiovasc Pharmacol 13:826-835.
14. Makielski JC and Falleroni MJ (1991) Temperature dependence of sodium current block by lidocaine in cardiac Purkinje cells. Am J Physiol 260:H681-H689.
15. Makielski JC, Sheets MF, Hanck DA, January CT and Fozzard HA (1987) Sodium current in voltage clamped internally perfused canine cardiac Purkinje cells. Biophys J 52:1-11.
16. + channels. Am J Physiol 275:H2016-H2024.
17. Nitta J, Sunami A, Marumo F and Hiraoka M (1992) State and sites of actions of flecainide on guinea-pig cardiac sodium channels. Eur J Pharmacol 214:191-197.
18. + channel blockade, β-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res 78:1009-1015.
19. + channels. Proc Natl Acad Sci USA 93:9270-9275.
20. Rosenfeld J, Sloanbrown K and George AL (1997) A novel muscle sodium channel mutation causes painful congenital myotonia. Ann Neurol 42:811-814.
21. Ca in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. Am J Physiol 256:C549-C559.
22. + channel blockade and to increase in heart rate: Implications for gene-specific therapy. Circulation 92:3381-3386.
23. Shander GS, Fan Z and Makielski JC (1995) Slowly recovering cardiac sodium current in rat ventricular myocytes: Effects of conditioning duration and recovery potential. J Cardiovasc Electrophysiol 6:786-795.
24. Shimizu W and Antzelevitch C (1997) Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 96:2038-2047.
25. Starmer CF (1987) Theoretical characterization of ion channel blockade. Competitive binding to periodically accessible receptors. Biophys J 52:405-412.
26. Starmer CF, Nesterenko VV, Undrovinas AI, Grant AO and Rosenshtraukh LV (1991) Lidocaine blockade of continuously and transiently accessible sites in cardiac sodium channels. J Mol Cell Cardiol 23:73-83.
27. Wang DW, George AL Jr and Bennett PB (1996a) Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels. Biophys J 70:238-245.
28. + current of guinea-pig ventricular myocytes. J Mol Cell Cardiol 28:893-903.
29. + channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci USA 93:13200-13205.
30. Wang DW, Yazawa K, Makita N, George AL Jr and Bennett PB (1997) Pharmacological targeting of long QT mutant sodium channels. J Clin Invest 99:1714-1720.
31. Wang Q, Shen J, Li Z, Timothy K, Vincent GM, Priori SG, Schwartz PJ and Keating MT (1995a) Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet 4:1603-1607.
32. Wang Z, Fermini B and Nattel S (1995b) Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther 272:184-196.
33. Windle JR, Geletka RC, Moss AJ and Atkins DL (1999) Normalization of Ventricular Repolarization with Flecainide in Patients with the LQT3 Form (SCN5A:ΔKPQ mutation) of Long QT Syndrome (Abstract). Circulation 100:1-80.